newsfilter
← Latest News
Business Wire·

Acorda Therapeutics to Present at Sequire Biotechnology Conference

Presentation on Thursday, February 2, 2023 at 3:00 p.m. ET Acorda Therapeutics, Inc. (NASDAQ:ACOR) announced that Ron Cohen, M.D., Acorda's President and Chief Executive Officer, will make a virtual presentation at the